The cancer community must seize the opportunity of the Natio...

With the government’s National Cancer Plan due for publication this autumn, we have an opportunity to fundamentally improve how we deliver innovation.

Current and future standard of care in prostate cancer

Despite recent advancements in the field of prostate cancer treatment, there remain distinct gaps in the current standard of care needing improvement.

The role of advanced imaging in transforming early detection...

The future of prostate cancer care lies in reimagining how we diagnose and monitor the disease.

12 Questions with Rick Coope

Rick Coope is General Manager at Menarini Stemline UK, Ireland, and the Nordics.

Doing good in people’s lives: Amy Burroughs discusses CML

Amy Burroughs, CEO, Terns Pharmaceuticals, discusses available treatments for CML, the potential of allosteric TKIs, and the wider oncology landscape.

From prostate cancer to breast cancer: In conversation with ...